Table 4.
Summary of subgroup analyses based on stent variety.
| Outcomes | Subgroup | Number of studies | Size of subgroup | Pooled rate (95% CI) | Heterogeneity between subgroups (P value) |
|---|---|---|---|---|---|
| Perioperative TIA | Wingspan | 11 | 704 | 2.39% (1.21–3.86%) | P = 0.536 |
| Off-label SES | 5 | 314 | 1.96% (0.52–4.05%) | ||
| Perioperative hemorrhagic stroke | Wingspan | 34 | 2,832 | 1.75% (1.20–2.38%) | P = 0.051 |
| Off-label SES | 18 | 1,133 | 0.89% (0.29–1.71%) | ||
| Perioperative ischemic stroke | Wingspan | 34 | 2,832 | 3.26% (2.13–4.57%) | P = 0.547 |
| Off-label SES | 18 | 1,133 | 2.81% (1.52–4.39%) | ||
| Perioperative stroke | Wingspan | 36 | 3,063 | 6.49% (4.87–8.28%) | P = 0.063 |
| Off-label SES | 18 | 1,133 | 4.34% (2.84–6.08%) | ||
| Perioperative death | Wingspan | 36 | 3,063 | 0.41% (0.14–0.79%) | P = 0.230 |
| Off-label SES | 18 | 1,070 | 0.12% (0.00–0.63%) | ||
| Perioperative stroke or death | Wingspan | 36 | 3,063 | 6.71% (5.05–8.55%) | P = 0.051 |
| Off-label SES | 18 | 1,133 | 4.38% (2.85–6.17%) | ||
| TIA beyond 30 days | Wingspan | 24 | 1,918 | 1.56% (0.43–3.18%) | P = 0.289 |
| Off-label SES | 14 | 665 | 0.54% (0.00–1.86%) | ||
| Ischemic stroke beyond 30 days | Wingspan | 28 | 2,204 | 3.67% (2.82–4.61%) | P = 0.002 |
| Off-label SES | 14 | 665 | 1.24% (0.35–2.48%) | ||
| Ischemic stroke or TIA beyond 30 days | Wingspan | 29 | 2,335 | 5.32% (3.59–7.29%) | P = 0.018 |
| Off-label SES | 15 | 839 | 2.29% (0.85–4.20%) | ||
| Death beyond 30 days | Wingspan | 25 | 2,130 | 0.68% (0.27–1.21%) | p = 0.179 |
| Off-label SES | 10 | 508 | 0.10% (0.00–0.90%) | ||
| Ischemic stroke or death beyond 30 days | Wingspan | 24 | 2,080 | 4.35% (2.76–6.23%) | P = 0.028 |
| Off-label SES | 10 | 508 | 1.66% (0.42–3.44%) | ||
| ISR | Wingspan | 26 | 1,289 | 15.73% (11.31–20.66%) | P = 0.036 |
| Off-label SES | 15 | 780 | 8.84% (4.80–13.79%) |
The off-label SES subgroup had better long-term outcomes than the Wingspan subgroup in terms of long-term ischemic stroke beyond 30 days, ischemic stroke or TIA beyond 30 days, ischemic stroke or death beyond 30 days, and ISR (P value < 0.05).